Cargando…
An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses
Adeno-associated viruses (AAV) have evolved to exploit the dynamic reorganization of host cell machinery during co-infection by adenoviruses and other helper viruses. In the absence of helper viruses, host factors such as the proteasome and DNA damage response machinery have been shown to effectivel...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526370/ https://www.ncbi.nlm.nih.gov/pubmed/26244496 http://dx.doi.org/10.1371/journal.ppat.1005082 |
_version_ | 1782384409793527808 |
---|---|
author | Schreiber, Claire A. Sakuma, Toshie Izumiya, Yoshihiro Holditch, Sara J. Hickey, Raymond D. Bressin, Robert K. Basu, Upamanyu Koide, Kazunori Asokan, Aravind Ikeda, Yasuhiro |
author_facet | Schreiber, Claire A. Sakuma, Toshie Izumiya, Yoshihiro Holditch, Sara J. Hickey, Raymond D. Bressin, Robert K. Basu, Upamanyu Koide, Kazunori Asokan, Aravind Ikeda, Yasuhiro |
author_sort | Schreiber, Claire A. |
collection | PubMed |
description | Adeno-associated viruses (AAV) have evolved to exploit the dynamic reorganization of host cell machinery during co-infection by adenoviruses and other helper viruses. In the absence of helper viruses, host factors such as the proteasome and DNA damage response machinery have been shown to effectively inhibit AAV transduction by restricting processes ranging from nuclear entry to second-strand DNA synthesis. To identify host factors that might affect other key steps in AAV infection, we screened an siRNA library that revealed several candidate genes including the PHD finger-like domain protein 5A (PHF5A), a U2 snRNP-associated protein. Disruption of PHF5A expression selectively enhanced transgene expression from AAV by increasing transcript levels and appears to influence a step after second-strand synthesis in a serotype and cell type-independent manner. Genetic disruption of U2 snRNP and associated proteins, such as SF3B1 and U2AF1, also increased expression from AAV vector, suggesting the critical role of U2 snRNP spliceosome complex in this host-mediated restriction. Notably, adenoviral co-infection and U2 snRNP inhibition appeared to target a common pathway in increasing expression from AAV vectors. Moreover, pharmacological inhibition of U2 snRNP by meayamycin B, a potent SF3B1 inhibitor, substantially enhanced AAV vector transduction of clinically relevant cell types. Further analysis suggested that U2 snRNP proteins suppress AAV vector transgene expression through direct recognition of intact AAV capsids. In summary, we identify U2 snRNP and associated splicing factors, which are known to be affected during adenoviral infection, as novel host restriction factors that effectively limit AAV transgene expression. Concurrently, we postulate that pharmacological/genetic manipulation of components of the spliceosomal machinery might enable more effective gene transfer modalities with recombinant AAV vectors. |
format | Online Article Text |
id | pubmed-4526370 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-45263702015-08-12 An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses Schreiber, Claire A. Sakuma, Toshie Izumiya, Yoshihiro Holditch, Sara J. Hickey, Raymond D. Bressin, Robert K. Basu, Upamanyu Koide, Kazunori Asokan, Aravind Ikeda, Yasuhiro PLoS Pathog Research Article Adeno-associated viruses (AAV) have evolved to exploit the dynamic reorganization of host cell machinery during co-infection by adenoviruses and other helper viruses. In the absence of helper viruses, host factors such as the proteasome and DNA damage response machinery have been shown to effectively inhibit AAV transduction by restricting processes ranging from nuclear entry to second-strand DNA synthesis. To identify host factors that might affect other key steps in AAV infection, we screened an siRNA library that revealed several candidate genes including the PHD finger-like domain protein 5A (PHF5A), a U2 snRNP-associated protein. Disruption of PHF5A expression selectively enhanced transgene expression from AAV by increasing transcript levels and appears to influence a step after second-strand synthesis in a serotype and cell type-independent manner. Genetic disruption of U2 snRNP and associated proteins, such as SF3B1 and U2AF1, also increased expression from AAV vector, suggesting the critical role of U2 snRNP spliceosome complex in this host-mediated restriction. Notably, adenoviral co-infection and U2 snRNP inhibition appeared to target a common pathway in increasing expression from AAV vectors. Moreover, pharmacological inhibition of U2 snRNP by meayamycin B, a potent SF3B1 inhibitor, substantially enhanced AAV vector transduction of clinically relevant cell types. Further analysis suggested that U2 snRNP proteins suppress AAV vector transgene expression through direct recognition of intact AAV capsids. In summary, we identify U2 snRNP and associated splicing factors, which are known to be affected during adenoviral infection, as novel host restriction factors that effectively limit AAV transgene expression. Concurrently, we postulate that pharmacological/genetic manipulation of components of the spliceosomal machinery might enable more effective gene transfer modalities with recombinant AAV vectors. Public Library of Science 2015-08-05 /pmc/articles/PMC4526370/ /pubmed/26244496 http://dx.doi.org/10.1371/journal.ppat.1005082 Text en © 2015 Schreiber et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Schreiber, Claire A. Sakuma, Toshie Izumiya, Yoshihiro Holditch, Sara J. Hickey, Raymond D. Bressin, Robert K. Basu, Upamanyu Koide, Kazunori Asokan, Aravind Ikeda, Yasuhiro An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses |
title | An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses |
title_full | An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses |
title_fullStr | An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses |
title_full_unstemmed | An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses |
title_short | An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses |
title_sort | sirna screen identifies the u2 snrnp spliceosome as a host restriction factor for recombinant adeno-associated viruses |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526370/ https://www.ncbi.nlm.nih.gov/pubmed/26244496 http://dx.doi.org/10.1371/journal.ppat.1005082 |
work_keys_str_mv | AT schreiberclairea ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT sakumatoshie ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT izumiyayoshihiro ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT holditchsaraj ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT hickeyraymondd ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT bressinrobertk ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT basuupamanyu ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT koidekazunori ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT asokanaravind ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT ikedayasuhiro ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT schreiberclairea sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT sakumatoshie sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT izumiyayoshihiro sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT holditchsaraj sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT hickeyraymondd sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT bressinrobertk sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT basuupamanyu sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT koidekazunori sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT asokanaravind sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses AT ikedayasuhiro sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses |